Introduction: Pancreatic resections for malignant or benign diseases are associated with
major morbidity and changes in physiology. To reduce perioperative complications and …

Objective Postoperative pancreatic fistula/POPF is the most feared complication in
pancreatic surgery. Although several systematic reviews investigated the impact of …

Background Leakage from the pancreatic stump is a leading cause of morbidity following
pancreatic surgery. It is essential to evaluate the effect of somatostatin analogues (SAs) …

Background The most common major complication after pancreatic resection is the
postoperative pancreatic fistula (POPF). Somatostatin analogs can reduce POPF, but the …

Background Post-operative pancreatic fistula (POPF) is a common complication of
pancreatic resection. Somatostatin analogues (SA) have been used as prophylaxis to …

Background: The use of somatostatin analogues (SAs) following pancreaticoduodenectomy
(PD) is controversial. Method: Literature databases were searched systematically for …

Background Prophylactic administration of somatostatin analogues (SA) to reduce the
incidence of post-operative pancreatic fistula (POPF) remains contentious. This meta …

Background The use of synthetic analogues of somatostatin following pancreatic surgery is
controversial. The aim of this meta-analysis is to determine whether prophylactic …

Introduction Postoperative pancreatic fistulas lead to substantially increased morbidity,
mortality, and healthcare costs after pancreatectomy. Studies have reported conflicting data …

Objective: The aim of this study was to evaluate the efficacy of somatostatin and its
analogues in prevention of postoperative complications after pancreaticoduodenectomy …